Anne E. White - Feb 10, 2023 Form 4 Insider Report for ELI LILLY & Co (LLY)

Role
EVP & Pres, Lilly Neuroscience
Signature
/s/ Jonathan Groff for Anne E. White, pursuant to authorization on file
Stock symbol
LLY
Transactions as of
Feb 10, 2023
Transactions value $
$1,231,842
Form type
4
Date filed
2/14/2023, 04:12 PM
Previous filing
Feb 3, 2023
Next filing
Feb 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LLY Common Stock Award $2.95M +8.56K +15.75% $345.12 62.9K Feb 10, 2023 Direct
transaction LLY Common Stock Sale -$857K -2.5K -3.97% $342.76 60.4K Feb 10, 2023 Direct F1
transaction LLY Common Stock Sale -$866K -2.5K -4.14% $346.47 57.9K Feb 13, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LLY Restricted Stock Unit Award $0 +4.12K $0.00 4.12K Feb 10, 2023 Common Stock 4.12K Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 2, 2022.
F2 Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.